| 000 | 01606 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512214036.0 | ||
| 264 | 0 | _c19800228 | |
| 008 | 198002s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM198002073020602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiris, E S | |
| 245 | 0 | 0 |
_aEffects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cFeb 1980 |
||
| 300 |
_a310-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Resorption _xetiology |
| 650 | 0 | 4 |
_aBone and Bones _xmetabolism |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aClodronic Acid _xpharmacology |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyproline _xurine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSherman, W H | |
| 700 | 1 | _aBaquiran, D C | |
| 700 | 1 | _aSchlatterer, J P | |
| 700 | 1 | _aOsserman, E F | |
| 700 | 1 | _aCanfield, R E | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 302 _gno. 6 _gp. 310-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM198002073020602 _zAvailable from publisher's website |
| 999 |
_c6444126 _d6444126 |
||